243 related articles for article (PubMed ID: 11602464)
1. Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells.
Mariette X
Ann Rheum Dis; 2001 Nov; 60(11):1007-10. PubMed ID: 11602464
[TBL] [Abstract][Full Text] [Related]
2. Lymphomas in patients with Sjögren's syndrome: review of the literature and physiopathologic hypothesis.
Mariette X
Leuk Lymphoma; 1999 Mar; 33(1-2):93-9. PubMed ID: 10194125
[TBL] [Abstract][Full Text] [Related]
3. Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas.
De Re V; De Vita S; Gasparotto D; Marzotto A; Carbone A; Ferraccioli G; Boiocchi M
Eur J Immunol; 2002 Mar; 32(3):903-10. PubMed ID: 11870635
[TBL] [Abstract][Full Text] [Related]
4. Secondary tumours in Sjögren's syndrome.
Kovács L; Szodoray P; Kiss E
Autoimmun Rev; 2010 Feb; 9(4):203-6. PubMed ID: 19602455
[TBL] [Abstract][Full Text] [Related]
5. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.
Ramos-Casals M; la Civita L; de Vita S; Solans R; Luppi M; Medina F; Caramaschi P; Fadda P; de Marchi G; Lopez-Guillermo A; Font J;
Arthritis Rheum; 2007 Feb; 57(1):161-70. PubMed ID: 17266090
[TBL] [Abstract][Full Text] [Related]
6. Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy.
De Vita S; Quartuccio L; Salvin S; Corazza L; Zabotti A; Fabris M
Rheumatology (Oxford); 2012 Apr; 51(4):627-33. PubMed ID: 22210656
[TBL] [Abstract][Full Text] [Related]
7. [Lymphoproliferative disorders in Sjögren's syndrome].
Prochorec-Sobieszek M; Wagner T
Otolaryngol Pol; 2005; 59(4):559-64. PubMed ID: 16273862
[TBL] [Abstract][Full Text] [Related]
8. Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses.
Royer B; Cazals-Hatem D; Sibilia J; Agbalika F; Cayuela JM; Soussi T; Maloisel F; Clauvel JP; Brouet JC; Mariette X
Blood; 1997 Jul; 90(2):766-75. PubMed ID: 9226177
[TBL] [Abstract][Full Text] [Related]
9. [Gougerot-Sjögren syndrome. Risk of lymphoma].
Mariette X
Presse Med; 1999 Jun; 28(22):1214-8. PubMed ID: 10414252
[TBL] [Abstract][Full Text] [Related]
10. Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells.
Martin T; Weber JC; Levallois H; Labouret N; Soley A; Koenig S; Korganow AS; Pasquali JL
Arthritis Rheum; 2000 Apr; 43(4):908-16. PubMed ID: 10765938
[TBL] [Abstract][Full Text] [Related]
11. Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management.
Nocturne G; Mariette X
Br J Haematol; 2015 Feb; 168(3):317-27. PubMed ID: 25316606
[TBL] [Abstract][Full Text] [Related]
12. Malignant lymphoma in primary Sjögren's syndrome: an update on the pathogenesis and treatment.
Routsias JG; Goules JD; Charalampakis G; Tzima S; Papageorgiou A; Voulgarelis M
Semin Arthritis Rheum; 2013 Oct; 43(2):178-86. PubMed ID: 23816048
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.
Mihăilă RG
World J Gastroenterol; 2016 Jul; 22(27):6214-23. PubMed ID: 27468211
[TBL] [Abstract][Full Text] [Related]
14. [Indications and options of new immune modulatory therapies for Sjögren's syndrome].
Feist E; Dörner T; Hansen A
Z Rheumatol; 2007 Dec; 66(8):679-85. PubMed ID: 17999070
[TBL] [Abstract][Full Text] [Related]
15. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
Voulgarelis M; Giannouli S; Tzioufas AG; Moutsopoulos HM
Ann Rheum Dis; 2006 Aug; 65(8):1033-7. PubMed ID: 16322082
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome.
Nocturne G; Virone A; Ng WF; Le Guern V; Hachulla E; Cornec D; Daien C; Vittecoq O; Bienvenu B; Marcelli C; Wendling D; Amoura Z; Dhote R; Lavigne C; Fior R; Gottenberg JE; Seror R; Mariette X
Arthritis Rheumatol; 2016 Apr; 68(4):977-85. PubMed ID: 26606524
[TBL] [Abstract][Full Text] [Related]
17. Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy.
De Vita S; Quartuccio L; Salvin S; Picco L; Scott CA; Rupolo M; Fabris M
Clin Exp Rheumatol; 2014; 32(4):490-4. PubMed ID: 24802131
[TBL] [Abstract][Full Text] [Related]
18. Sjögren's syndrome associated with chronic hepatitis C - the benefit of the antiviral treatment.
Prunoiu C; Georgescu EF; Georgescu M; Simionescu C
Rom J Morphol Embryol; 2008; 49(4):557-62. PubMed ID: 19050807
[TBL] [Abstract][Full Text] [Related]
19. Stereotypic rheumatoid factors that are frequently expressed in mucosa-associated lymphoid tissue-type lymphomas are rare in the labial salivary glands of patients with Sjögren's syndrome.
Bende RJ; Slot LM; Hoogeboom R; Wormhoudt TA; Adeoye AO; Guikema JE; van Noesel CJ
Arthritis Rheumatol; 2015 Apr; 67(4):1074-83. PubMed ID: 25546553
[TBL] [Abstract][Full Text] [Related]
20. Salivary Gland Mucosa-Associated Lymphoid Tissue-Type Lymphoma From Sjögren's Syndrome Patients in the Majority Express Rheumatoid Factors Affinity-Selected for IgG.
Bende RJ; Janssen J; Beentjes A; Wormhoudt TAM; Wagner K; Haacke EA; Kroese FGM; Guikema JEJ; van Noesel CJM
Arthritis Rheumatol; 2020 Aug; 72(8):1330-1340. PubMed ID: 32182401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
